Hims & Hers Health is trading 9.83% higher at €27.26, with no clear company-specific catalyst identified for the September 22–23, 2026 move. - Coverage highlighted securities-fraud lawsuits announced September 21, a negative legal overhang rather than an explanation for the rally. - Broader indexes were essentially flat, offering no clear market-wide explanation for the gain.